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Abstract
Globoid-cell Leukodystrophy (GLD; Krabbe’s disease) is a rapidly progressing inherited demyelinating disease caused by a
deficiency of the lysosomal enzyme Galactosylceramidase (GALC). Deficiency of GALC leads to altered catabolism of
galactosylceramide and the cytotoxic lipid, galactosylsphingosine (psychosine). This leads to a rapidly progressive fatal
disease with spasticity, cognitive disability and seizures. The murine model of GLD (Twitcher; GALC2/2) lacks the same
enzyme and has similar clinical features. The deficiency of GALC leads to oligodendrocyte death, profound
neuroinflammation, and the influx of activated macrophages into the CNS. We showed previously that keratinocyte
chemoattractant factor (KC) is highly elevated in the CNS of untreated Twitcher mice and significantly decreases after
receiving a relatively effective therapy (bone marrow transplantation combined with gene therapy). The action of KC is
mediated through the CXCR2 receptor and is a potent chemoattractant for macrophages and microglia. KC is also involved
in oligodendrocyte migration and proliferation. Based on the commonalities between the disease presentation and the
functions of KC, we hypothesized that KC and/or CXCR2 contribute to the pathogenesis of GLD. Interestingly, the course of
the disease is not significantly altered in KC- or CXCR2-deficient Twitcher mice. There is also no alteration in inflammation or
demyelination patterns in these mice. Furthermore, transplantation of CXCR2-deficient bone marrow does not alter the
progression of the disease as it does in other models of demyelination. This study highlights the role of multiple redundant
cytokines and growth factors in the pathogenesis of GLD.
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Introduction
Globoid-cell leukodystrophy (GLD, Krabbe’s disease) is a
rapidly progressive demyelinating disease with an autosomal
recessive inheritance [1]. The disease is caused by a deficiency
of the lysosomal enzyme galactosylceramidase (GALC). In the
absence of GALC activity, the cytotoxic sphingolipid, galactosyl-
sphingosine (psychosine) accumulates in the central (CNS) and
peripheral nervous systems (PNS) [2]. Oligodendrocytes are
particularly susceptible to elevated levels of psychosine [3–5].
Oligodendrocyte dysfunction and subsequent death are prominent
features of GLD [3,6]. The murine model of GLD (the Twitcher
mouse) is deficient in GALC activity and shares many of the
biochemical and histological features of the human disease [7].
Hence, the Twitcher mouse has been widely used to better
understand the underlying pathogenesis and develop effective
therapies for GLD.
CNS inflammation is a prominent histopathologic feature of
GLD and is characterized by the presence of globoid cells
(macrophages with engulfed myelin debris) and activated astro-
cytes in the CNS [8–10]. There is also an increase in pro-
inflammatory cytokines and chemokines as well as an increase of
T-cells and B-cells in the CNS of these animals [11–13]. It appears
that inflammation could be a disease-altering target when
considering treatment for GLD. Deletion of MHC Ia has been
shown to alter the course of the disease in the Twitcher mouse
[14]. Bone marrow transplantation (BMT) is one of the currently
used treatments for the disease. It has been shown that BMT alone
or in combination with gene therapy is associated with reduced
CNS inflammation [9,10]. There is also an associated reduction in
pro-inflammatory cytokines and chemokines that correlate with
the efficacy of therapy [10,15,16].
We show here that Keratinocyte Chemoattractant factor (KC) is
greatly elevated in the brain and spinal cord of Twitcher mice. We
also showed previously that the levels of KC decrease in response
to a relatively effective therapy [10]. Keratinocyte chemoattractant
factor belongs to the CXC family of chemokines and is a potent
macrophage and neutrophil chemoattractant [17–19]. Keratino-
cyte chemoattractant signaling through its receptor, CXCR2,
synergizes with another oligodendrocyte mitogen, platelet derived
growth factor (PDGF) to cause oligodendrocyte precursor cell
(OPC) proliferation, but can also act independently to cause
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migration arrest [20]. Since oligodendrocyte death and dysfunc-
tion as well as inflammation are observed in the CNS of Twitcher
mice, we investigated the role of KC and its receptor CXCR2 in
the two inter-related aspects of the disease. Our experiments
demonstrate that global deficiency of KC or CXCR2 does not
significantly influence the progression of GLD in the Twitcher
mouse. We also demonstrate that the lack of KC or the lack of
signaling through the CXCR2 receptor on donor hematopoietic-
derived cells does not affect the disease progression in a bone
marrow transplant setting. Interestingly, we found that there are
several other cytokines and growth factors that are upregulated in
the Twitcher CNS (e.g. MIP-2, PDGF-BB and FGF-2). Since
some of these growth factors and cytokines have redundant
functions in CNS inflammation, demyelination, and remyelina-
tion, it is possible that they fully compensate for the lack of KC
and CXCR2. This study defines the role of KC and CXCR2 in
the progression of inflammation in the Twitcher mouse and
highlights the redundancy inherent in the cytokine/chemokine
system.
Materials and Methods
Animal Procedures
Heterozygous (GALC +/2) mice and mice expressing GFP
under the control of the pCAGGS promoter (GFP mice) were
obtained from The Jackson Laboratory (Bar Harbor, ME) and
maintained under the supervision of M.S.S. at Washington
University School of Medicine. Heterozygous CXCR2 mice
(CXCR2+/2) on the C57Bl/6J background were a kind gift from
Dr. Ann Richmond (Vanderbilt University, Nashville, TN).
Heterozygous KC mice (KC+/2) on the C57Bl/6J background
were a kind gift from Dr. Sergio Lira (Mount Sinai School of
Medicine, NewYork, NY). All the mice used in this study (KC2/2,
Figure 1. Cytokine and chemokine levels in the CNS of Twitcher mice. The fold-elevation of various cytokines/chemokines in the brain is
shown. Among all the assayed molecules, the chemokine KC showed the greatest fold change in the brains (.15-fold increase) of the Twitcher mice
(A). The levels of KC in the brains (B) and the spinal cords (C) of the Twitcher mice showed a progressive increase with time. The vertical bars
represent the means and the error bars represent one SEM; **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0064647.g001
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CXCR22/2, GALC2/2 and GFP transgenic mice) were
congenic on the C57Bl/6J background.
The mice were housed under standard conditions in a
pathogen-free facility with ad libitum access to food and water.
The Twitcher mice (GALC2/2) were obtained by heterozygous
matings between GALC+/2 mice. The breeding strategy that was
used in order to generate the other experimental animals was as
follows: Homozygous KC2/2 mice were bred with heterozygous
Twitcher (GALC+/2) mice. Progeny were screened for double
heterozygotes (KC+/2GALC+/2). The double heterozygote
mice (KC+/2GALC+/2) mice were bred to obtain KC2/
2GALC+/2 mice. Experimental animals (KC2/2GALC2/2)
were generated by crossing the KC2/2 GALC+/2 mice with
mice of the same genotype. Within the same colony, KC+/
+GALC+/2 animals were used as breeders to obtain KC+/
+GALC2/2 animals. In order to obtain CXCR22/2GALC2/
2 mice, a similar strategy was used, except that the experimental
animals were generated by breeding CXCR2+/2GALC+/2
male and female, or CXCR2+/2GALC+/2 female with
CXCR22/2GALC+/2 male. The CXCR2-deficient mice were
maintained on antibiotic water (Trimethoprim/Sulphamethoxa-
zole) as they are known to be susceptible to infections.
To generate Twitcher-GFP mice, GFP transgenic mice (GFP+)
were bred with GALC+/2 mice. The bone marrow donors were
generated by crossing GALC+/2 GFP+ or GALC+/+GFP+
mice. To generate CXCR22/2GFP+ mice, the CXCR2+/2
mice were bred with GFP+ mice. The CXCR2+/2GFP+ mice
were bred to generate CXCR22/2GFP+ mice. These mice were
maintained as separate colonies and were used as donors for bone
marrow transplantation.
Genotyping
PCR for GALC was done using the protocol described
previously [21]. The following primers were used for genotyping
KC [17]: 59- GAA GAC AGA CTG CTC TGA TGG CAC -39
and 59-CCC TTC TAC TAG CAC AGT GGT TGA-39. The
following primers were used for genotyping CXCR2 [18]: 59-CCT
CGT ACT GCG TAT CCT GCC TCA G-39 and 59-TAG CCA
TGA TCT TGA GAA GTC CAT G-39. The lack of KC or
CXCR2 was confirmed by the presence of NeoR cassette in the
same PCR reaction. The NeoR primers used were: 59-GGA TTG
CAC GCA GGT TCT-39 and 59-GGA CAG GTC GGT CTT
GAC AAA-39. Homozygous deletion of KC protein was
confirmed in two PCR-identified founder mice through Bio-plex
kit (Bio-Rad laboratories, Hercules, CA). Homozygous deletion of
the CXCR2 receptor was confirmed by flow cytometry of bone
marrow from two PCR-identified CXCR22/2 mice using anti-
mouse CXCR2-APC antibody (R & D systems, Minneapolis,
MN). GFP phenotype was determined using an ultraviolet lamp
held on the ventral surface of the newborn mice to detect
fluorescence under the skin.
Figure 2. Flow cytometric characterization of inflammatory cells in the KC2/2GALC2/2 brains. The upper row of Panel A contains
representative bivariate contour plots showing CD8 and CD4 T-cells at day 36 in various groups of mice. The lower row in panel A contain
representative bivariate contour plots showing activated microglia (CD45hi CD11b+, upper right quadrant) isolated from the brain at 36 days of age.
There is no significant increase in CD8+ T-cells in KC2/2GALC+/+, KC+/+GALC2/2 or KC2/2GALC2/2 mice compared to the KC+/+GALC+/+ mice
(B). There is no significant difference in the CD4+ T-cells in the brains of the KC2/2GALC2/2 and KC+/+GALC2/2 mice compared to the KC+/
+GALC+/+ mice (C). There is no significant difference between the KC+/+GALC2/2 mice and KC2/2GALC2/2 mice in the number of activated
microglia (D).
doi:10.1371/journal.pone.0064647.g002
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Bone Marrow Transplantation
Animals were genotyped by PCR on postnatal day 9 using
previously published protocols [17,18,21]. Nine-day-old mice
received 900 rads of total body c-radiation from a 137Cs source
for conditioning followed by intraperitoneal injection of 3–
46107 GFP(+), unfractionated bone marrow cells approximately
24 hours after irradiation [22]. Post-transplantation antibiotics
included trimethoprim/sulfamethoxazole added to the water.
Bone marrow donors were sex-matched GALC+/+CXCR2+/+,
GALC +/+CXCR22/2, or GALC2/2CXCR2+/+ mice, all
expressing GFP under the CAGGS promoter [23].
Flow Cytometry
Flow cytometry was used to quantify the hematopoietic-derived
cells in the CNS and measure bone-marrow chimerism with
donor-derived GFP+ cells after transplantation. For quantifying
the hematopoietic-derived cells in the CNS, perfused mice brains
were homogenized with collagenase/DNase buffer and passed
through a 70 mm strainer [24,25]. Collagenase/DNase buffer was
made using 50 mg/ml collagenase D stock, 100 ug/ml TLCK
trypsin inhibitor stock (Sigma, St. Louis, MO), DNase I 1 mg/ml
stock, 1 M Hepes, pH 7.4 and Hank’s buffered salt solution.
Collagenase D stock was made by dissolving 100 mg collagenase
in 2 ml of TESCA buffer (50 mM TES, 0.36 mM Calcium
chloride, pH7.4 at 37uC). DNase stock was made by dissolving
bovine pancreatic DNAase (Sigma, St. Louis, MO) in 0.15 M
NaCl.
The hematopoietic-derived cells were isolated from the
homogenate by separation on a percoll gradient. Total number
of cells isolated were estimated by sampling 20 ml of cells and
counting them using a hemocytometer. The cells were stained with
fluorophore-conjugated antibodies after Fc receptor block (BD
biosciences, San Jose, CA). The following cells were identified and
quantified by flow cytometry: activated microglia/macrophages
(CD45hi CD11b+), resting microglia (CD45lo CD11b+), CD8+ T-
cells, CD4+ T-cells [26,27] and Neutrophils (Gr1hi F4/80–) [28].
The data was acquired on a FACSCalibur flow cytometer (BD
biosciences, San Jose, CA) using Cell Quest software (BD
biosciences, San Jose, CA) and analyzed using FloJo software
(Tree Star, Inc., Ashland, OR). Individual cell counts were
obtained by multiplying the percentages of the various cell
populations obtained by flow cytometry with the total cell counts.
A total number of 3–6 mice per group were used for analysis.
Spleen and bone marrow cells were used for positive controls. For
quantifying donor engraftment, bone marrow was harvested from
the femur and the percentage of GFP+ cells was determined.
Cytokine Sandwich Immunoassays
The methods used in this study are as described previously
[10,29]. Briefly, animals were perfused with ice cold PBS after
deep anesthesia. The brains and spinal cords were collected and
homogenized in 10 mM Tris, 150 mM NaCl, 1 mM Dithiothre-
itol, 0.2% Triton-X100 and 20 ml/ml of Protease Inhibitor
Cocktail (P8340, Sigma, St. Louis, MO). The supernatant was
diluted to 0.5–2 mg protein/ml and the samples were stored at
270oC until use. The total n of 3–4 samples were used per group.
The concentration of various cytokines and chemokines was
determined using Bio-plex kit (Bio-Rad laboratories, Hercules,
CA). The 23-plex sample kit includes the standards and antibodies
for the following cytokines: IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5,
IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-17, Eotaxin,
G-CSF, GM-CSF, IFN-c, KC, MCP-1, MIP-1a, MIP-1b,
RANTES and TNF-a. A 3-plex kit for analyzing MIP-2, FGF-2
and PDGF-BB was separately used. The supernatant from brain
and spinal cord homogenates was incubated with the fluorescent
beads, washed and then incubated with biotin-labeled antibody
cocktail. The samples were then incubated with streptavidin-
Phycoerythrin and the fluorescence values were read in the Bio-
Plex 2200 system (Bio-Rad laboratories, Hercules, CA). Standard
curves were generated for each cytokine using the standards
supplied with the kit and the individual cytokine concentration in
each sample was estimated. Protein concentrations of the samples
were determined using the Coomasie dye-binding assay (Bio-Rad,
Hercules, CA).
Figure 3. LFB/PAS staining of Twitcher mice lacking KC or CXCR2. Histology of the brains showing LFB staining (blue) and PAS staining (pink)
in the corpus callosum (A-D) and cerebellum (E-H) in the wildtype, Twitcher, KC2/2GALC2/2 mice and CXCR22/2GALC2/2 mice. The KC2/
2GALC2/2 forebrain (C) and cerebellum (G) show histology which is essentially identical to the Twitcher mice (KC+/+GALC2/2; B and F) with
similar myelin staining and distribution of globoid cells. The CXCR22/2GALC2/2 mouse brains also demonstrate similar histology (D, H) compared
to the Twitcher mice (B, F). There is no apparent difference between the KC+/+GALC+/+ and KC2/2GALC+/+ or the CXCR22/2GALC+/+ mice in all
the sections examined (images not shown). Scale bar equals 50 mm.
doi:10.1371/journal.pone.0064647.g003
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Figure 4. Oligodendrocyte precursor proliferation in the lumbar spinal cord of twitcher mice lacking KC or CXCR2. Arrowheads in
panels A-D identify oligodendrocyte precursors expressing NG2 (red) with a more dendritic morphology. Arrowheads also identify the regions
highlighted in the higher magnification insets. Minimal BrdU staining (green) was noted in wildtype mice (A) (scale bar, 25 mm). In B, C and D, the
arrowheads identify proliferating oligodendrocytes that co-stain for NG2 (red) and BrdU (green). Blue represents nuclear staining with DAPI. There is
no statistically significant difference in the total number of NG2+ cells in the spinal cords of various groups (E). A statistically significant (*** p,0.001)
increase in number of NG2+BrdU+ cells/field is seen in the Twitcher and CXCR22/2 GALC2/2 spinal cords compared to WT mice (F). There is no
significant difference in the number of NG2+BrdU+ cells in KC2/2GALC2/2mice compared to Wildtype, Twitcher, or CXCR22/2 GALC2/2 groups.
doi:10.1371/journal.pone.0064647.g004
Figure 5. Effect of CXCR2 and KC bone marrow chimeras on the progression of GLD. The survival of Twitcher mice transplanted with
CXCR2-deficient bone marrow (green, GALC+/+CXCR22/2 to Twitcher) or KC2/2GALC2/2 mice transplanted with wild type bone marrow (black,
wildtype to KC2/2GALC2/2) is not significantly different from Twitcher mice receiving wild type bone marrow (blue, wildtype to twitcher) (A).
Twitcher mice transplanted with Twitcher bone marrow (red, Twitcher to Twitcher) have a similar survival (median age= 45 days) compared to
untransplanted Twitcher mice (data not shown). The weights of various bone marrow chimeras are not significantly different from each other, but are
significantly decreased compared to the wild type controls (B).
doi:10.1371/journal.pone.0064647.g005
Role of KC and CXCR2 in Krabbe Disease
PLOS ONE | www.plosone.org 5 June 2013 | Volume 8 | Issue 6 | e64647
Histology and Immunofluorescence
For oligodendrocyte proliferation studies, the animals were
injected with 5 mg/kg BrdU (Bromodeoxyuridine; Sigma, St.
Louis, MO) every 8 hours for four days starting on day 32 of age.
The lumbar spinal cords were collected after perfusion of the
animals with PBS and 4% paraformaldehyde. The tissue was fixed
in Enhanced Decalcification Formulation (SL85-32, Statlab,
Lewisville, TX) for 2 days and cryoprotected in 30% sucrose.
The tissues were then frozen in O.C.T. compound (Sakura
Finetek, Torrance, CA) and cryosectioned. For immunostaining,
the sections were co-stained with 1:50 dilution of a rabbit anti-
NG2 antibody (ab5320, Millipore, Billerica, MA) and 1:100
dilution of mouse anti-BrdU (B2531, Sigma, St. Louis, MO)
overnight at 4oC. The primary antibodies were detected using an
anti-rabbit antibody conjugated to Alexafluor 555 (A-21428,
Invitrogen, Carlsbad, CA) and a goat anti-mouse antibody
conjugated to Alexa 488 (A-11001, Invitrogen, Carlsbad, CA).
The images were acquired using a Ziess laser confocal microscope
(Carl Ziess Microimaging, LLC, Thornwood, NY). The images
were acquired using LSM/Axioskop software (Carl Ziess Micro-
imaging, LLC, Thornwood, NY). Ten sections from each group
with n= 4 animals per group were used for analysis. The cell
counts were done manually. For luxol-fast blue (LFB) and periodic
acid-Schiff (PAS) staining, the tissues were fixed overnight in 4%
paraformaldehyde after perfusion with ice cold PBS and then
transferred to 30% sucrose. The tissues were embedded in paraffin
and the LFB and PAS staining was done using standard methods.
Statistical Methods
GraphPad prism (GraphPad Software, Inc., La Jolla, CA) was
used for statistical analyses and for generating graphs. Two-way
unmatched ANOVA followed by post-hoc Bonferroni compari-
sons were used for analyzing the cytokine/chemokine data. One-
way ANOVA followed by post-hoc Bonferroni comparisons were
used for comparing various groups analyzed by FACS and for the
analysis of oligodendrocyte progenitors. Log-rank test was used to
compare the Kaplan-Meier survival curves. For statistical analysis
of body weights, repeated measures ANOVA could not be used
because of attrition, therefore one-way ANOVA at pre-deter-
mined time points was used instead.
Results
Altered Cytokine Profiles
Since inflammation is a prominent feature of GLD, and
previous studies [10,12,30] have shown alterations in certain
cytokines, a more comprehensive survey of cytokines and
chemokines in the brains and spinal cords of Twitcher mice was
performed at various time points. Several cytokines/chemokines
were altered in the brains and spinal cords of Twitcher mice at
different time points (Figure 1). Among the altered molecules, the
chemokine KC was elevated 16–25-fold in the Twitcher brain and
spinal cord compared to the wildtype (Figure 1). This elevation is
progressive in both the brains and the spinal cords of Twitcher
mice (Figures 1B and C). Other cytokines that were altered
significantly include IL-12 (p40) and IL-9 in the brain (Figure 1A).
Several other, non-statistically significant changes were observed,
including an increase in the cytokines IL-3, G-CSF, MCP-1, and
MIP-1B and a decrease in the cytokines IL-5, IL-6 and IL-10 in
the brain (Figure 1A).
Inflammation, Histology and Lifespan in KC2/2GALC2/2
Mice
Given the role of KC in macrophage chemotaxis and
oligodendrocyte development and the dramatic elevation in the
Twitcher mouse brain and spinal cord, we hypothesized that KC
contributes to the pathogenesis of GLD. In order to test this
hypothesis, we generated mice lacking KC and GALC (KC2/
2GALC2/2). Since elevated KC correlated with an increase in
activated microglia/macrophages (CD45hiCD11b+) in the
Twitcher mice [10], we further hypothesized that Twitcher mice
lacking KC would have decreased activated microglia/macro-
phages in the CNS and a milder disease course. Surprisingly,
KC2/2GALC2/2 mice did not show any quantitative differ-
ences in the various inflammatory cells in the brain or spinal cord,
when compared with that of KC+/+GALC2/2 mice (Figure 2).
The inflammatory cells from the brains and the spinal cords of the
various groups of mice were isolated and stained for CD4, CD8,
CD11b and CD45 using flourophore-conjugated antibodies.
These cells were quantified using flow cytometry (as described in
Materials and Methods). The upper row in Figure 2A shows the
contour plots of CD4 and CD8 T-cells in the brain. The upper left
and the lower right quadrants in each of these bivariate plots
represent CD4 and CD8 T-cells respectively. Similarly, the lower
row in Figure 2A shows the bivariate contour plots for cells stained
with CD11b and CD45 flourophore-conjugated antibodies. The
lower right and the upper right quadrants represent resting
microglia (CD45loCD11b+) and activated microglia
(CD45hiCD11b+) respectively. There is no significant difference
between KC2/2GALC+/+ and the KC2/2GALC2/2
groups in terms of the CD4, CD8 and the activated microglial
numbers. Similar results are seen in the spinal cords, except for a
significant increase in CD4 T-cells in the spinal cords of KC+/
+GALC2/2 mice compared to KC2/2GALC2/2 mice (data
not shown). In addition, histology of the brain and spinal cord did
not reveal any major differences when examined using LFB
Figure 6. Altered cytokine and growth factor levels in the spinal cord of Twitcher mice that could possibly compensate for the lack
of KC or CXCR2. MIP-2 (CXCL2) (A), PDGF-BB (B), and FGF-2 (C) levels are significantly and progressively elevated in the spinal cords of the Twitcher
mice. Vertical bars represent the mean and the error bars represent one SEM (**p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0064647.g006
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(myelin) or PAS (globoid cells) staining (Figure 3C and G). Finally,
there was no alteration in the lifespan or body weight of KC2/
2GALC2/2 mice when compared with the KC+/+GALC2/2
mice (data not shown).
Inflammation, Histology and Lifespan in CXCR22/
2GALC2/2 Mice
The similarity in the inflammatory profile between Twitcher
mice with and without KC could be due to redundancy amongst
the receptors for KC. KC is known to bind two chemokine
receptors, CXCR1 and CXCR2 [31]. The receptor CXCR2 is
more widely distributed throughout the CNS compared to
CXCR1 and multiple ligands act on the CXCR2 receptor [32].
Deletion of CXCR2 will eliminate signaling by KC through that
receptor as well as signaling by other molecules that could
compensate for the action of KC. Therefore, we would expect that
the consequences of CXCR2 deletion might be more dramatic
than CXCR1 deletion. We hypothesized that Twitcher mice
lacking CXCR2 would have decreased activated microglia/
macrophages in the CNS and a milder disease course. Therefore,
we generated CXCR22/2GALC2/2 mice in order to test the
above hypothesis. When the brains of CXCR22/2GALC2/2
mice were compared to CXCR2+/+GALC2/2 mice, there was
no qualitative difference in LFB/PAS staining between the two
groups (Figure 3D and H). There was also no difference between
the CXCR2-deficient Twitcher mice and CXCR2-positve
Twitcher mice in the profile of inflammatory cells in the brain
as measured by flow cytometry (data not shown). Finally, there was
no difference in lifespan or body weight in the CXCR22/
2GALC2/2 mice when compared to CXCR2+/+GALC2/2
mice (data not shown).
Role of KC and CXCR2 in Oligodendrocyte Proliferation
The striking elevation of KC in the brains and spinal cords of
the Twitcher mice seem to have no apparent effect on the cellular
inflammatory profile in the CNS. Another important function of
KC and CXCR2 is to promote the differentiation and prolifer-
ation of oligodendrocytes [20]. KC and CXCR2 have been shown
to be involved in oligodendrocyte precursor proliferation and
migration in other mouse models of demyelinating diseases such as
the cuprizone model, Jimpy mice (defective proteolipid protein),
and mice with Theiler’s virus-induced demyelinating disease
[33,34]. Consistent with an increase in KC in the CNS, it has
been reported previously that there is an increase in proliferating
oligodendrocytes in the spinal cord of the Twitcher mice [35],
possibly to replace those cells lost in the course of disease.
Therefore, we hypothesized that KC elevation is important in
promoting oligodendrocyte proliferation seen in the Twitcher
spinal cord. We quantified the number of oligodendrocyte
precursors (NG2+ cells) and the number of proliferating
oligodendrocyte cells by Brdu/NG2 double immunostaining
(Figure 4). There is no significant difference in the total number
of NG2+ cells in the spinal cord of wildtype, Twitcher, KC2/
2GALC2/2 or CXCR22/2GALC2/2 mice (Figure 4E).
However, we found a significant increase in the number of
NG2+BrdU+ cells in the Twitcher spinal cord, compared to
wildtype (Figure 4F). There was no significant difference in the
number of NG2+BrdU+ cells among any of the GALC2/2
groups (Figure 4F). This suggests that the lack of KC and CXCR2
does not significantly influence the proliferation of the NG2+
oligodendrocytic cells in the spinal cord.
Selective CXCR2 or KC Deficiency in the Bone Marrow or
CNS of Twitcher Mice does not Alter the Disease Course
Previous studies have shown that CXCR2+ cells are involved in
demyelination. Transplantation of CXCR2-deficient bone mar-
row decreases the severity of demyelination in the cuprizone
model [36,37]. In the current study, global lack of KC or CXCR2
in Twitcher mice does not alter the activated microglia/
macrophages or prevent demyelination. However, it is possible
that the beneficial effect of KC and CXCR2 deficiency in the bone
marrow and other peripheral tissues are negated by their lack in
the CNS or vice-versa, where they may be important in promoting
repair. Therefore, we hypothesized that selective deficiency of
CXCR2 in the bone marrow compartment or global deficiency of
KC, including the CNS, would lead to decrease inflammation and
alter the course of the disease. In the Twitcher mice, bone marrow
transplantation supplies GALC activity to the CNS, and by itself
prolongs the lifespan [38,39]. Therefore, appropriate transplanta-
tion groups were used to control for this therapeutic effect.
Twitcher mice transplanted with GALC+/+ CXCR22/2 bone
marrow did not have an increased lifespan compared to Twitcher
mice transplanted with GALC+/+CXCR2+/+ bone marrow
(Figure 5A). Likewise, GALC2/2KC2/2 mice transplanted
with GALC+/+CXCR2+/+ bone marrow did not have a
significantly increased lifespan. Hematopoietic chimerism deter-
mined at 36 days of age (26d post-transplant), showed that the
engraftment of various groups is between 40 and 60% (data not
shown). There was also no difference in the weights of the various
groups of Twitcher mice that received transplantation (Figure 5B).
Elevation of other Chemokines and Growth Factors
Since neither KC nor CXCR2 deficiency in the CNS had any
measurable effects on the disease progression, other cytokines or
growth factors, or both might be compensating for these
deficiencies. Measurement of cytokines that could potentially act
on CXCR2 (for e.g., CXCL2 or MIP-2), and other oligodendro-
cyte mitogens such as FGF-2 and PDGF-BB (Figure 6) show that
there is a significant and progressive elevation in their levels with
time in the spinal cord of Twitcher mice.
Discussion
We show here that KC is highly elevated in both the brain and
spinal cord of Twitcher mice. The elevation of KC in the Twitcher
mouse was similar to that seen in other mouse models of
demyelinating disease with infiltrating immune cells like Jimpy
mice [34], Theiler’s encephalitis and EAE mice [40]. We
previously showed that KC levels were nearly normalized in the
brains of Twitcher mice following a relatively efficacious therapy
(BMT combined with AAV-mediated gene therapy) [10]. A
similar increase in KC was observed in an independent study
performed in the Twitcher mouse [16]. In that study KC was not
significantly decreased when Twitcher mice were transplanted
with GALC+/+ mesenchymal stem cells (MSC). The differences
between those two studies were the mode of treatment and the
degree of response. The combination of BMT and gene therapy
resulted in an increase in median life span of ,82 days whereas
the increase in life span following MSC transplantation was
,5 days. Collectively, these data indicate that KC is responsive to
a relatively effective treatment regimen and imply that KC might
be involved in the disease pathogenesis.
Macrophage (globoid cell) infiltration into the brain and spinal
cord is a hallmark of GLD, and it is believed to be pathogenic.
Since KC and its receptor are known to be involved in
macrophage recruitment [19], we hypothesized that increased
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levels of KC exacerbated the disease by recruitment and activation
of microglia/macrophages into the CNS. In contrast to our
prediction, there was neither a decrease in the number of activated
microglia nor was there an alteration in the overall course of the
disease in Twitcher mice lacking KC. Contrary to our expectation,
there were activated microglia/macrophages in the CNS of the
Twitcher mice lacking KC. This implies that KC is not required
for the recruitment/activation of the microglia and macrophages
or there are redundant pathways that can compensate for KC.
Keratinocyte chemoattractant factor functions through either
the CXCR1 or CXCR2 receptor. Although, both CXCR1 and
CXCR2 are known receptors for KC, only CXCR2 is expressed
in the CNS [41]. Since the CXCR1 receptor is not as widely
expressed in the CNS as CXCR2, we believed that CXCR1 would
play less of a role in GLD compared to CXCR2. Furthermore,
several other chemokines (CXCL1–3, 6 and 7) also act on CXCR2
[42]. It is possible that elevation of any of the other four ligands
could compensate for the lack of KC, explaining the lack of effect
observed by eliminating KC. Since there is considerable redun-
dancy among the cytokines and chemokines, we hypothesized that
any compensatory effects of other ligands binding to CXCR2
could be determined by studying the progression of disease in
Twitcher mice lacking the chemokine receptor CXCR2. Similar
to KC-deficiency, there was no alteration in the globoid-cells or
the overall course of the disease in the CXCR22/2GALC2/2
mice compared to the CXCR2+/+GALC2/2 mice. This
observation could be explained again by the redundancy in the
chemokine system. It is possible that KC could act on its
alternative receptor CXCR1 [41] and bring about the same effects
in the absence of CXCR2. Unfortunately, the severity of the
Twitcher and CXCR2-deficient phenotypes precluded the gener-
ation of a mouse triply deficient in GALC, CXCR2, and KC (or
CXCR1).
The chemokine KC and its receptor CXCR2 are also known to
be involved in oligodendrocyte proliferation. The role of KC and
CXCR2 in other animal models of remyelination are complex
[43]. The findings in this study are consistent with a previous study
[35] showing that proliferating NG2+ oligodendrocyte precursors
were increased in the spinal cords of Twitcher mice. However, in
the current study, the lack of KC or CXCR2 had no effect on the
number of proliferating oligodendrocyte precursors compared to
Twitcher mice. Other growth factors like FGF-2 and PDGF-BB
are known to affect oligodendrocyte differentiation and migration
and may compensate for the lack of KC. Interestingly, both FGF-2
and PDGF-BB are highly elevated in the spinal cords of Twitcher
mice.
In a recent study, it was shown that hematopoietic chimeras
using CXCR2-deficient donor bone marrow have reduced
demyelination in response to cuprizone exposure [37]. It appears
that the lack of CXCR2 decreases the number of neutrophils (and
possibly macrophages) that migrate into the CNS and subse-
quently reduces demyelination. When similar bone marrow
chimeras were made in the GALC-deficient mice, no such effect
was seen, possibly implying that the myelin damage in the
Twitcher mouse is very profound with minimal to no effect of the
immune system on the disease progression. Alternatively, the
partial bone marrow chimerism obtained by irradiating 9–10 day
old mice could spare enough CXCR2-positive cells in the bone
marrow to cause demyelination.
To summarize, although KC is highly elevated in the CNS of
the Twitcher mice, its deficiency, and the deficiency of its receptor
CXCR2, has no apparent effect on the inflammation, oligoden-
drocyte proliferation, or on the overall progression of the disease.
These findings highlight the profound and rapid nature of the
disease in the Twitcher mice and emphasize the redundancy
within the chemokine system. It appears that therapies targeting
individual cytokine systems or oligodendrocyte proliferation/
myelin repair would be ineffective if the primary enzyme
deficiency is not corrected. Although effective therapies like
BMT plus CNS-directed gene therapy tend to normalize KC
levels, there may be additional and independent mechanisms by
which the therapeutic effect occurs. The roles of these additional
independent mechanisms have to be explored in future studies. A
more complete understanding of these mechanisms would provide
a better understanding of how therapies like BMT contribute to
the therapeutic benefit in GLD.
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